Mitral Regurgitation Market, Global Outlook and Forecast 2023-2029

Report ID: MMG63278 | Category: Medical Care | Pages: 118 | Format: PDF | Published Date: March 03,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Mitral regurgitation (MR) is the backflow of blood from the left ventricle into the left atrium during left ventricular systole. The mitral valve is located in the opening between the left atrium and the left ventricle. It opens to allow blood from the left atrium to fill the left ventricle. When the left ventricle contracts, the mitral valve closes so that pumped blood can only flow into the aorta. When the mitral valve is not fully closed, some blood can leak back into the left atrium. Mitral regurgitation can be divided into primary and secondary MR according to the pathogenesis. Primary mitral regurgitation is due to the pathological changes of one or more of the mitral valve leaflets, valve annulus, chordae tendineae and papillary muscles, such as degenerative disease or rheumatic disease, which cause the mitral valve to fail to close normally. Secondary mitral valve regurgitation is functional mitral valve regurgitation, which is caused by the disease of the heart itself or the valve supporting structure, such as pathological changes of the myocardium leading to pathological dilatation of the left ventricle and mitral valve annulus or Mitral regurgitation due to localized displacement of the left ventricle and subvalvular device. The current quantitative assessment of mitral valve regurgitation, the current standards of various guidelines and documents are not completely consistent, generally divided into mild, moderate and severe, this classification is relatively broad, can not well reflect the changes and manifestations before and after surgery effect of surgery. In the MitraClip system clinical trial, mitral regurgitation was divided into no (0+), mild (1+), moderate (2+), moderate to severe (3+), severe (4+), and then more This classification method is used in several clinical studies of mitral valve regurgitation interventional therapy.
This report aims to provide a comprehensive presentation of the global market for Mitral Regurgitation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mitral Regurgitation. This report contains market size and forecasts of Mitral Regurgitation in global, including the following market information:
Global Mitral Regurgitation Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Mitral Regurgitation market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Primary Mitral Regurgitation Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Mitral Regurgitation include Edwards Lifesciences, Abbott, CardioSolution, NeoChord, Mitralign, Medtronic, Boston Scientific, Mitralix and Shanghai Hanyu Medical Technology, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Mitral Regurgitation companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mitral Regurgitation Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Mitral Regurgitation Market Segment Percentages, by Type, 2022 (%)
    Primary Mitral Regurgitation
    Secondary Mitral Regurgitation
Global Mitral Regurgitation Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Mitral Regurgitation Market Segment Percentages, by Application, 2022 (%)
    Transapical
    Via Stock and Via Interstitial
    Right Internal Jugular Vein
Global Mitral Regurgitation Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Mitral Regurgitation Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Mitral Regurgitation revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Mitral Regurgitation revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Edwards Lifesciences
    Abbott
    CardioSolution
    NeoChord
    Mitralign
    Medtronic
    Boston Scientific
    Mitralix
    Shanghai Hanyu Medical Technology
    Valgen Holding Corporation
    NeoChord
    CoreMedic
    Babic Chord
    Gore Medical
    Valtech Cardio
    Transcardiac
    ChoRe
    AVVIE
    Cardiovalve
    HighLife SAS
    Neovasc
    MitrAssist Lifesciences
    Shanghai NewMed Medical
    Peijia Medical
    MicroPort CardioFlow Medtech
Outline of Major Chapters:
Chapter 1: Introduces the definition of Mitral Regurgitation, market overview.
Chapter 2: Global Mitral Regurgitation market size in revenue.
Chapter 3: Detailed analysis of Mitral Regurgitation company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Mitral Regurgitation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Mitral Regurgitation Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Mitral Regurgitation Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Mitral Regurgitation Overall Market Size
    2.1 Global Mitral Regurgitation Market Size: 2022 VS 2029
    2.2 Global Mitral Regurgitation Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Mitral Regurgitation Players in Global Market
    3.2 Top Global Mitral Regurgitation Companies Ranked by Revenue
    3.3 Global Mitral Regurgitation Revenue by Companies
    3.4 Top 3 and Top 5 Mitral Regurgitation Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Mitral Regurgitation Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Mitral Regurgitation Players in Global Market
        3.6.1 List of Global Tier 1 Mitral Regurgitation Companies
        3.6.2 List of Global Tier 2 and Tier 3 Mitral Regurgitation Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Mitral Regurgitation Market Size Markets, 2022 & 2029
        4.1.2 Primary Mitral Regurgitation
        4.1.3 Secondary Mitral Regurgitation
    4.2 By Type - Global Mitral Regurgitation Revenue & Forecasts
        4.2.1 By Type - Global Mitral Regurgitation Revenue, 2018-2023
        4.2.2 By Type - Global Mitral Regurgitation Revenue, 2024-2029
        4.2.3 By Type - Global Mitral Regurgitation Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Mitral Regurgitation Market Size, 2022 & 2029
        5.1.2 Transapical
        5.1.3 Via Stock and Via Interstitial
        5.1.4 Right Internal Jugular Vein
    5.2 By Application - Global Mitral Regurgitation Revenue & Forecasts
        5.2.1 By Application - Global Mitral Regurgitation Revenue, 2018-2023
        5.2.2 By Application - Global Mitral Regurgitation Revenue, 2024-2029
        5.2.3 By Application - Global Mitral Regurgitation Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Mitral Regurgitation Market Size, 2022 & 2029
    6.2 By Region - Global Mitral Regurgitation Revenue & Forecasts
        6.2.1 By Region - Global Mitral Regurgitation Revenue, 2018-2023
        6.2.2 By Region - Global Mitral Regurgitation Revenue, 2024-2029
        6.2.3 By Region - Global Mitral Regurgitation Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Mitral Regurgitation Revenue, 2018-2029
        6.3.2 US Mitral Regurgitation Market Size, 2018-2029
        6.3.3 Canada Mitral Regurgitation Market Size, 2018-2029
        6.3.4 Mexico Mitral Regurgitation Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Mitral Regurgitation Revenue, 2018-2029
        6.4.2 Germany Mitral Regurgitation Market Size, 2018-2029
        6.4.3 France Mitral Regurgitation Market Size, 2018-2029
        6.4.4 U.K. Mitral Regurgitation Market Size, 2018-2029
        6.4.5 Italy Mitral Regurgitation Market Size, 2018-2029
        6.4.6 Russia Mitral Regurgitation Market Size, 2018-2029
        6.4.7 Nordic Countries Mitral Regurgitation Market Size, 2018-2029
        6.4.8 Benelux Mitral Regurgitation Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Mitral Regurgitation Revenue, 2018-2029
        6.5.2 China Mitral Regurgitation Market Size, 2018-2029
        6.5.3 Japan Mitral Regurgitation Market Size, 2018-2029
        6.5.4 South Korea Mitral Regurgitation Market Size, 2018-2029
        6.5.5 Southeast Asia Mitral Regurgitation Market Size, 2018-2029
        6.5.6 India Mitral Regurgitation Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Mitral Regurgitation Revenue, 2018-2029
        6.6.2 Brazil Mitral Regurgitation Market Size, 2018-2029
        6.6.3 Argentina Mitral Regurgitation Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Mitral Regurgitation Revenue, 2018-2029
        6.7.2 Turkey Mitral Regurgitation Market Size, 2018-2029
        6.7.3 Israel Mitral Regurgitation Market Size, 2018-2029
        6.7.4 Saudi Arabia Mitral Regurgitation Market Size, 2018-2029
        6.7.5 UAE Mitral Regurgitation Market Size, 2018-2029
7 Mitral Regurgitation Companies Profiles
    7.1 Edwards Lifesciences
        7.1.1 Edwards Lifesciences Company Summary
        7.1.2 Edwards Lifesciences Business Overview
        7.1.3 Edwards Lifesciences Mitral Regurgitation Major Product Offerings
        7.1.4 Edwards Lifesciences Mitral Regurgitation Revenue in Global Market (2018-2023)
        7.1.5 Edwards Lifesciences Key News & Latest Developments
    7.2 Abbott
        7.2.1 Abbott Company Summary
        7.2.2 Abbott Business Overview
        7.2.3 Abbott Mitral Regurgitation Major Product Offerings
        7.2.4 Abbott Mitral Regurgitation Revenue in Global Market (2018-2023)
        7.2.5 Abbott Key News & Latest Developments
    7.3 CardioSolution
        7.3.1 CardioSolution Company Summary
        7.3.2 CardioSolution Business Overview
        7.3.3 CardioSolution Mitral Regurgitation Major Product Offerings
        7.3.4 CardioSolution Mitral Regurgitation Revenue in Global Market (2018-2023)
        7.3.5 CardioSolution Key News & Latest Developments
    7.4 NeoChord
        7.4.1 NeoChord Company Summary
        7.4.2 NeoChord Business Overview
        7.4.3 NeoChord Mitral Regurgitation Major Product Offerings
        7.4.4 NeoChord Mitral Regurgitation Revenue in Global Market (2018-2023)
        7.4.5 NeoChord Key News & Latest Developments
    7.5 Mitralign
        7.5.1 Mitralign Company Summary
        7.5.2 Mitralign Business Overview
        7.5.3 Mitralign Mitral Regurgitation Major Product Offerings
        7.5.4 Mitralign Mitral Regurgitation Revenue in Global Market (2018-2023)
        7.5.5 Mitralign Key News & Latest Developments
    7.6 Medtronic
        7.6.1 Medtronic Company Summary
        7.6.2 Medtronic Business Overview
        7.6.3 Medtronic Mitral Regurgitation Major Product Offerings
        7.6.4 Medtronic Mitral Regurgitation Revenue in Global Market (2018-2023)
        7.6.5 Medtronic Key News & Latest Developments
    7.7 Boston Scientific
        7.7.1 Boston Scientific Company Summary
        7.7.2 Boston Scientific Business Overview
        7.7.3 Boston Scientific Mitral Regurgitation Major Product Offerings
        7.7.4 Boston Scientific Mitral Regurgitation Revenue in Global Market (2018-2023)
        7.7.5 Boston Scientific Key News & Latest Developments
    7.8 Mitralix
        7.8.1 Mitralix Company Summary
        7.8.2 Mitralix Business Overview
        7.8.3 Mitralix Mitral Regurgitation Major Product Offerings
        7.8.4 Mitralix Mitral Regurgitation Revenue in Global Market (2018-2023)
        7.8.5 Mitralix Key News & Latest Developments
    7.9 Shanghai Hanyu Medical Technology
        7.9.1 Shanghai Hanyu Medical Technology Company Summary
        7.9.2 Shanghai Hanyu Medical Technology Business Overview
        7.9.3 Shanghai Hanyu Medical Technology Mitral Regurgitation Major Product Offerings
        7.9.4 Shanghai Hanyu Medical Technology Mitral Regurgitation Revenue in Global Market (2018-2023)
        7.9.5 Shanghai Hanyu Medical Technology Key News & Latest Developments
    7.10 Valgen Holding Corporation
        7.10.1 Valgen Holding Corporation Company Summary
        7.10.2 Valgen Holding Corporation Business Overview
        7.10.3 Valgen Holding Corporation Mitral Regurgitation Major Product Offerings
        7.10.4 Valgen Holding Corporation Mitral Regurgitation Revenue in Global Market (2018-2023)
        7.10.5 Valgen Holding Corporation Key News & Latest Developments
    7.11 NeoChord
        7.11.1 NeoChord Company Summary
        7.11.2 NeoChord Business Overview
        7.11.3 NeoChord Mitral Regurgitation Major Product Offerings
        7.11.4 NeoChord Mitral Regurgitation Revenue in Global Market (2018-2023)
        7.11.5 NeoChord Key News & Latest Developments
    7.12 CoreMedic
        7.12.1 CoreMedic Company Summary
        7.12.2 CoreMedic Business Overview
        7.12.3 CoreMedic Mitral Regurgitation Major Product Offerings
        7.12.4 CoreMedic Mitral Regurgitation Revenue in Global Market (2018-2023)
        7.12.5 CoreMedic Key News & Latest Developments
    7.13 Babic Chord
        7.13.1 Babic Chord Company Summary
        7.13.2 Babic Chord Business Overview
        7.13.3 Babic Chord Mitral Regurgitation Major Product Offerings
        7.13.4 Babic Chord Mitral Regurgitation Revenue in Global Market (2018-2023)
        7.13.5 Babic Chord Key News & Latest Developments
    7.14 Gore Medical
        7.14.1 Gore Medical Company Summary
        7.14.2 Gore Medical Business Overview
        7.14.3 Gore Medical Mitral Regurgitation Major Product Offerings
        7.14.4 Gore Medical Mitral Regurgitation Revenue in Global Market (2018-2023)
        7.14.5 Gore Medical Key News & Latest Developments
    7.15 Valtech Cardio
        7.15.1 Valtech Cardio Company Summary
        7.15.2 Valtech Cardio Business Overview
        7.15.3 Valtech Cardio Mitral Regurgitation Major Product Offerings
        7.15.4 Valtech Cardio Mitral Regurgitation Revenue in Global Market (2018-2023)
        7.15.5 Valtech Cardio Key News & Latest Developments
    7.16 Transcardiac
        7.16.1 Transcardiac Company Summary
        7.16.2 Transcardiac Business Overview
        7.16.3 Transcardiac Mitral Regurgitation Major Product Offerings
        7.16.4 Transcardiac Mitral Regurgitation Revenue in Global Market (2018-2023)
        7.16.5 Transcardiac Key News & Latest Developments
    7.17 ChoRe
        7.17.1 ChoRe Company Summary
        7.17.2 ChoRe Business Overview
        7.17.3 ChoRe Mitral Regurgitation Major Product Offerings
        7.17.4 ChoRe Mitral Regurgitation Revenue in Global Market (2018-2023)
        7.17.5 ChoRe Key News & Latest Developments
    7.18 AVVIE
        7.18.1 AVVIE Company Summary
        7.18.2 AVVIE Business Overview
        7.18.3 AVVIE Mitral Regurgitation Major Product Offerings
        7.18.4 AVVIE Mitral Regurgitation Revenue in Global Market (2018-2023)
        7.18.5 AVVIE Key News & Latest Developments
    7.19 Cardiovalve
        7.19.1 Cardiovalve Company Summary
        7.19.2 Cardiovalve Business Overview
        7.19.3 Cardiovalve Mitral Regurgitation Major Product Offerings
        7.19.4 Cardiovalve Mitral Regurgitation Revenue in Global Market (2018-2023)
        7.19.5 Cardiovalve Key News & Latest Developments
    7.20 HighLife SAS
        7.20.1 HighLife SAS Company Summary
        7.20.2 HighLife SAS Business Overview
        7.20.3 HighLife SAS Mitral Regurgitation Major Product Offerings
        7.20.4 HighLife SAS Mitral Regurgitation Revenue in Global Market (2018-2023)
        7.20.5 HighLife SAS Key News & Latest Developments
    7.21 Neovasc
        7.21.1 Neovasc Company Summary
        7.21.2 Neovasc Business Overview
        7.21.3 Neovasc Mitral Regurgitation Major Product Offerings
        7.21.4 Neovasc Mitral Regurgitation Revenue in Global Market (2018-2023)
        7.21.5 Neovasc Key News & Latest Developments
    7.22 MitrAssist Lifesciences
        7.22.1 MitrAssist Lifesciences Company Summary
        7.22.2 MitrAssist Lifesciences Business Overview
        7.22.3 MitrAssist Lifesciences Mitral Regurgitation Major Product Offerings
        7.22.4 MitrAssist Lifesciences Mitral Regurgitation Revenue in Global Market (2018-2023)
        7.22.5 MitrAssist Lifesciences Key News & Latest Developments
    7.23 Shanghai NewMed Medical
        7.23.1 Shanghai NewMed Medical Company Summary
        7.23.2 Shanghai NewMed Medical Business Overview
        7.23.3 Shanghai NewMed Medical Mitral Regurgitation Major Product Offerings
        7.23.4 Shanghai NewMed Medical Mitral Regurgitation Revenue in Global Market (2018-2023)
        7.23.5 Shanghai NewMed Medical Key News & Latest Developments
    7.24 Peijia Medical
        7.24.1 Peijia Medical Company Summary
        7.24.2 Peijia Medical Business Overview
        7.24.3 Peijia Medical Mitral Regurgitation Major Product Offerings
        7.24.4 Peijia Medical Mitral Regurgitation Revenue in Global Market (2018-2023)
        7.24.5 Peijia Medical Key News & Latest Developments
    7.25 MicroPort CardioFlow Medtech
        7.25.1 MicroPort CardioFlow Medtech Company Summary
        7.25.2 MicroPort CardioFlow Medtech Business Overview
        7.25.3 MicroPort CardioFlow Medtech Mitral Regurgitation Major Product Offerings
        7.25.4 MicroPort CardioFlow Medtech Mitral Regurgitation Revenue in Global Market (2018-2023)
        7.25.5 MicroPort CardioFlow Medtech Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Mitral Regurgitation Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?